CPhI Japan 2020 Postponed

27 Feb 2020

Rescheduling will ensure all stakeholders can take part in a successful exhibition and conference.

CPhI Japan will be postponed until a new date later in the year after extensive consultation with key stakeholders and consideration of all alternatives. The event, which was due to take place 16-18 March at the Big Sight Exhibition Centre in Tokyo will be rescheduled due to the increasingly complex travel arrangements many of its attendees are experiencing as a result of COVID-19.

CPhI Japan 2020 Postponed

The decision was taken after many of the event’s largest stakeholders – international exhibitors and major pharmaceutical employees – reported that they would be unable to travel to the exhibition at this time.

“The event is now in its 18th edition and we have always listened to the feedback of our exhibitors and attendees. Due to unforeseen circumstances of COVID-19, many felt that it will be difficult to travel to the exhibition at this time. We will work with our attendees and exhibitors so that we can deliver another successful event for everyone involved. We wanted to communicate this as fast as possible, and we will confirm the new dates imminently. I thank our partners for their continued support and understanding, and we express our solidarity with those affected around the world,” commented Christopher Eve, Managing Director, Informa Markets and UBM Japan.

Read More

Related news

CPhI announces new pharma events calendar for 2020

CPhI announces new pharma events calendar for 2020

17 Mar 2020

Organizers secure three new dates for events in Japan, South East Asia and North America in response to COVID-19.

Read more 
The game is on for connected devices

The game is on for connected devices

20 Feb 2020

The future of value-added medicines will see gamification transforming the engagement of therapies.

Read more 
CPhI South East Asia rescheduled for July 2020

CPhI South East Asia rescheduled for July 2020

18 Feb 2020

Event move ensures extra precautions and safety measures taken

Read more 
Report predicts booming ASEAN generics export market for 2020

Report predicts booming ASEAN generics export market for 2020

13 Feb 2020

The changing opportunities are attributed to rising GMP standards and increased regional harmonization.

Read more 
Innovation awarded at Pharmapack

Innovation awarded at Pharmapack

10 Feb 2020

Innovations across primary and secondary packaging, drug delivery devices, and machinery acknowledged in Exhibitor Innovations, with Health Product Awards for patient-centricity and eco-design.

Read more 
Digital value-added medicines - a key driver for 2020

Digital value-added medicines - a key driver for 2020

29 Jan 2020

Pharmapack also identifies waste management and the use of blockchain as key trends for the year ahead.

Read more 
CPhI and AAPS partner to expand expert scientific content at CPhI North America

CPhI and AAPS partner to expand expert scientific content at CPhI North America

10 Jan 2020

CPhI and the American Association of Pharmaceutical Scientists (AAPS) today announced a partnership to expand the scientific content of activities sponsored by CPhI, including CPhI North America—the only event to bring the entire North American pharmac...

Read more 
Innovation and regulatory harmonisation to drive Indian pharma in 2020

Innovation and regulatory harmonisation to drive Indian pharma in 2020

18 Dec 2019

Experts suggest the continued goal of aligning India to Western regulatory standards will help the country sustain significant increases in exports.

Read more 
Connectivity, customization and sustainability driving packaging and drug delivery in 2020

Connectivity, customization and sustainability driving packaging and drug delivery in 2020

4 Dec 2019

Pharmapack 2020 gathering top specialists and pioneers to exchange their vision on best strategies to tackle key challenges.

Read more 
Worldwide event predicts global pharma trends for 2020

Worldwide event predicts global pharma trends for 2020

27 Nov 2019

Content sessions identify value-added medicines, preventive drugs, early diagnostics and patient experience as some of the trends for the year ahead.

Read more